About Clerio Vision

Clerio Vision was founded by leading scientists and experienced medical entrepreneurs based on groundbreaking research from the University of Rochester. The research used femtosecond lasers for noninvasive vision correction in contact lenses, the human cornea and intraocular lenses (IOLs).

Today, Clerio Vision is working on its Laser Induced Refractive Index Correction (LIRIC) technology to overcome the safety and performance issues with existing refractive surgery, contacts lenses and IOL options.

Clerio Vision has raised approximately  $40 million  in financing from Safar Partners, Stonehenge Growth Equity, Armory Square Ventures, prominent angel investors and the National Science Foundation. The company has teams in Rochester, NY, Florida and California working in research, manufacturing and sales.

ABOUT CLERIO VISION 

Clerio Vision was founded based on groundbreaking research from the University of Rochester using femtosecond lasers for noninvasive vision correction in contact lenses, the human cornea and intraocular lenses (IOLs). We are dedicated to providing a wide array of solutions to the millions of patients requiring vision correction.

Headquarters 

& Operations

1892 S. Winton Rd.

Rochester, NY 14618

Contact Lens

Manufacturing & Sales

7575 Commerce Court

Sarasota, FL 34243                    

Contact Lens  

Research Center

205 Summit Point Dr.

Henrietta, NY 14467

 

Refractive Surgery

Research Center

1435 Koll Circle Suite 105

San Jose, CA 95112